US Patent 8138328 Modulation of apolipoprotein (A) expression

Patent 8138328 was granted and assigned to Ionis Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ionis Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8138328

Date of Patent

March 20, 2012

Patent Application Number

12765647

Date Filed

April 22, 2010

Patent Citations Received

‌

US Patent 11859180 Antisense oligonucleotide compositions

Patent Primary Examiner

‌

Amy Bowman

Patent abstract

Compounds, compositions and methods are provided for modulating the expression of apolipoprotein(a). The compositions comprise oligonucleotides, targeted to nucleic acid encoding apolipoprotein(a). Methods of using these compounds for modulation of apolipoprotein(a) expression and for diagnosis and treatment of disease associated with expression of apolipoprotein(a) are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8138328 Modulation of apolipoprotein (A) expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API